The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.
about
A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteers.Rapid decline in insulin antibodies and glutamic acid decarboxylase autoantibodies with ibrutinib therapy of chronic lymphocytic leukaemia.Bruton's Tyrosine Kinase, a Component of B Cell Signaling Pathways, Has Multiple Roles in the Pathogenesis of Lupus.PKK deficiency in B cells prevents lupus development in Sle lupus mice.
P2860
The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.
@en
type
label
The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.
@en
prefLabel
The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.
@en
P2093
P2860
P1476
The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.
@en
P2093
Jonathan H Sheehan
Leslie J Crofford
Lindsay E Nyhoff
Peggy L Kendall
P2860
P304
P356
10.1586/1744666X.2016.1152888
P577
2016-02-11T00:00:00Z